STM Article Repository

The functional food industrial canopy linked potential exhibiting investigation on hypolipidemic and antioxidant efficacy of tomato puree lycopene has been emerged out as a next generation research folio likely to be beneficial for innovative start up mission. New generation consumer demand base nutrition superimposing health claim fostering food products linked with value addition is underlined as a new dimension of functional foods. In present study the health claim exploration ability of lycopene rich tomato puree as a novel food ingredient was assessed by animal studies to project hypolipidemic efficacy to reduce risk of selective non-communicable diseases. The data analysis, interpretation and reviewed literature infusion collectively underlined the efficacy of lycopene (tomato puree) in monitoring atherogenesis mechanism through synergic mode of action of notified specialty features (total cholesterol, serum triglycerides, LDL cholesterol and HDL cholesterol) and projected an effective gateway to support disease infused health claim assessment. Lycopene has several cardiovascular health benefits such as antioxidative, anti-inflammatory, anti-atherogenic, cardioprotective, antiplatelet effect, improving endothelial function (nitric oxide bioavailability and blood flow), metabolic profile (by impairing cholesterol synthesis) and blood pressure control. The cumulative decrease in total cholesterol of treated rats (159.99 to 126.40mg/dl), serum triglycerides (114.81 to 107.34mg/dl), LDL cholesterol (40.19 to 32.90mg/dl) and increase in HDL cholesterol (19.99 to 23.87mg/dl) represents hypolipidemic efficacy of tomato puree lycopene. The development of a prototype for CVD to launch a health claim was rationally updated by the tomato puree mass, a viable source of lycopene with innate antiatherogenic efficacy. The human clinical study as a confirmation tool, may be the best option for next generation research.